Leerink Partners analyst David Larsen reiterated an Outperform rating and $180 price target on athenahealth (NASDAQ: ATHN) announced a new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE